← Eichor
Condition: Metastatic Testicular Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Metastatic Testicular Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial
Phase N/A · 5 location(s) · University of Southern California · NCT06060873Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer
NA · 1 location(s) · Sahlgrenska University Hospital · NCT07498959The TASTY-steering Study
NA · 11 location(s) · University Medical Center Groningen · NCT07258563Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · 582 location(s) · National Cancer Institute (NCI) · NCT03866382Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumo
NA · 12 location(s) · Centre Leon Berard · NCT05588700Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT07218913
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.